Gut microbiome / neuroinflammation

Class

Sodium oligomannate (gut-microbiome-modulating)

This mechanism concerns the gut microbiome — the community of bacteria and other microorganisms living in the intestine — and its influence on inflammation within the nervous system, a process called neuroinflammation. Research over the past decades has shown that gut bacteria do not stay confined to the digestive tract: they produce metabolites (small molecules) that enter the bloodstream and interact with the immune system. When the balance of gut bacteria is disturbed, a state known as dysbiosis, these metabolites can promote pro-inflammatory immune activity that eventually contributes to inflammation in the brain, a process increasingly linked to neurodegenerative conditions such as Alzheimer's disease. Sodium oligomannate is an orally taken oligosaccharide, a short chain of sugar units, derived from marine algae, that works by reshaping the composition of gut bacteria rather than by acting directly on a brain receptor or enzyme. The rationale is that by correcting dysbiosis, the amount of inflammatory metabolite production is reduced, dampening the peripheral immune signals that would otherwise propagate to the central nervous system and drive glial cell activation and amyloid-associated pathology. This gut-brain axis approach represents a distinct strategy from conventional central-nervous-system drugs that cross the blood-brain barrier to act locally.